Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia

Cancer Immunology Immunotherapy

Volumn 43, Issue 2, 1996, Pages 103-108

  Weiss, Lola ^a   Nusair, Samir ^a   Reich, Shoshana ^a   Sidi, Haim ^a   Slavin, Shimon ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

bone marrow transplantation; graft; leukemia effects; lymphokine activated immunotherapy

Indexed keywords

RECOMBINANT INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LEUKEMIA; BONE MARROW TRANSPLANTATION; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BONE MARROW; BONE MARROW CELLS; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; LEUKEMIA, B-CELL; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES;

EID: 10544246086     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050309     Document Type: Article

References (17)

1. Anderson KC, Goodnough LT, Sayers M, Pisciotto PT, Kurtz SR, Lane TA, Anderson CS, Silberstein LE (1991) Variation in blood component irradiation practice: Implications for prevention of transfusion-associated graft-versus-host disease. Blood 77: 2096
2. Horowitz MM, Gale RP, Sondel PM (1990) Graft versus leukemia reactions after bone marrow transplantation. Blood 75: 555
3. Malkovsky M, Brenner MK, Hung R, Rastan S, Dore C, Brown S, North ME, Asherson GL, Prentice HG, Medawar PB (1986) T-cell depletion of allogeneic bone marrow prevents accelerated graft-versus-host disease induced by exogenous interleukin 2. Cell Immunol 103: 476
4. Okunewick JP, Meredith RF (1981) Graft-versus-leukemia in man and animal models. Boca Raton. CRC, Boca Raton, Fla, pp 1-265
5. Or R, Nagler A, Ackerstein A, Naparstek E, Samuel S, Drakos P, Kapelushnik J, Amar A, Slavin S (1993) Allogeneic cell mediated cytokine activated immunotherapy of non-Hodgkin lymphoma for eradication of minimal residual disease in conjunction with autologous bone marrow transplantation (ABMT). Blood 82: [Suppl 1] 171
6. Palathumpat V, Holm B, Dejbaksh-Jones S, Strober S (1992) Treatment of BCL 1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells. J Immunol 148: 3319
7. Ringden O, Horowitz MM (1989) Graft-vs-leukemia reactions in humans. Transpl Proc 21: 2989
8. Slavin S, Strober S (1978) Spontaneous murine B-cell leukemia. Nature 272: 624
9. Slavin S, Weiss L, Morecki S, Ben Bassat H, Leizerowitz R, Gamliel H, Korkesh A, Voss R, Polliack A (1981) Ultrastructural, cell membrane and cytogenetic characteristics of B-cell leukemia (BCL 1), a murine model of chronic lymphocytic leukemia. Cancer Res 41: 4162
10. Slavin S, Weiss L, Morecki S, Weigensberg M (1981) Eradication of murine leukemia with histoincompatible marrow grafts in mice conditioned with total lymphoid irradiation (TLI). Cancer Immunol Immunother 11: 155
11. Slavin S, Eckerstein A, Weiss L (1988) Adoptive immunotherapy in conjunction with bone marrow transplantation - amplification of natural host defense mechanisms against cancer by recombinant IL2. Nat Immun Cell Growth Regul 7: 180
12. Slavin S, Naparstek E, Nagler A, Ackerstein A, Drakos P, Kapelushnik J, Brautbar C, Or R (1993) Cell mediated immunotherapy (CMI) for the treatment of malignant hematological diseases in conjunction with autologous bone marrow transplantation (ABMT). Blood 82: [Suppl 1] 292a
13. Sykes M, Romick ML, Hoyles KA, Sachs DH (1990) In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents grafts-versus-host disease mortality and permits alloengraftment. J Exp Med 171: 645
14. Sykes M, Romick ML, Sachs DH (1990) Interleukin 2 prevents graft-vs-host disease without diminishing the graft-vs-leukemia effect of allogeneic lymphocytes. Proc Natl Acad Sci USA 87: 5633
15. Truitt RL, Lefever AV, Shish CC (1987) Graft-vs-leukemia reactions: experimental models and clinical trials. In: Gale RP, Champlin R (eds) Progress in bone marrow transplantation. Liss, New York, pp 219-232
16. Van Lochern E, De Gast B, Goulmy E (1992) In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities. Bone Marrow Transpl 10: 181
17. Weiss L, Weigensberg M, Morecki S, Bar S, Cobbold S, Waldmann H, Slavin S (1990) Characterization of effector cells of graft vs leukemia (GVL) following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia (BCL 1). Cancer Immunol Immunother 31: 236